Under normal circumstances, unblinding the entire trial prematurely can ONLY be ordered by the DSMB.
This has happened on occasion where efficacy has become obvious, but is highly unlikely to occur in a study like ACLs p3 (even if the efficacy is damn good).
Add to My Watchlist
What is My Watchlist?